# NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot Trial

> **NCT02667041** · NA · COMPLETED · sponsor: **University of Ottawa** · enrollment: 20 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DEVICE:** NeuroQore rTMS Device

## Key facts

- **NCT ID:** NCT02667041
- **Lead sponsor:** University of Ottawa
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02667041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02667041, "NeuroQore rTMS (Monophasic vs. Biphasic) for Major Depressive Disorder: A Randomized Controlled Pilot Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02667041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*